russ2000_1429|BTX|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|sga_expense|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|price_next_month|price_second_month
russ2000_1429|BTX|1|Brooklyn ImmunoTherapeutics Inc Total Current Assets (Quarterly) (USD)|Brooklyn ImmunoTherapeutics Inc Cash and Short Term Investments (Quarterly) (USD)|Brooklyn ImmunoTherapeutics Inc Inventories (Quarterly) (USD)|Brooklyn ImmunoTherapeutics Inc Net PP&E (Quarterly) (USD)|Brooklyn ImmunoTherapeutics Inc Goodwill and Intangibles (Quarterly) (USD)|Brooklyn ImmunoTherapeutics Inc Total Liabilities (Quarterly) (USD)|Brooklyn ImmunoTherapeutics Inc Total Current Liabilities (Quarterly) (USD)|Brooklyn ImmunoTherapeutics Inc Total Long Term Liabilities (Quarterly) (USD)|Brooklyn ImmunoTherapeutics Inc Total Deposits (Quarterly) (USD)|Brooklyn ImmunoTherapeutics Inc Book Value (Quarterly) (USD)|Brooklyn ImmunoTherapeutics Inc Retained Earnings (Quarterly) (USD)|Brooklyn ImmunoTherapeutics Inc Treasury Stock (Quarterly) (USD)|Brooklyn ImmunoTherapeutics Inc EV to Revenues|Brooklyn ImmunoTherapeutics Inc EV to Earnings|Brooklyn ImmunoTherapeutics Inc EV to Free Cash Flow|Brooklyn ImmunoTherapeutics Inc EV to Assets (Quarterly)|Brooklyn ImmunoTherapeutics Inc PS Ratio|Brooklyn ImmunoTherapeutics Inc PE Ratio|Brooklyn ImmunoTherapeutics Inc Price to Book Value|Brooklyn ImmunoTherapeutics Inc PEG Ratio|Brooklyn ImmunoTherapeutics Inc Debt to Equity Ratio|Brooklyn ImmunoTherapeutics Inc Dividend Yield|Brooklyn ImmunoTherapeutics Inc Shareholder Yield (TTM)|Brooklyn ImmunoTherapeutics Inc Percent of Shares Outstanding Short|Brooklyn ImmunoTherapeutics Inc Total Receivables (Quarterly) (USD)|Brooklyn ImmunoTherapeutics Inc Total Payables (Quarterly) (USD)|Brooklyn ImmunoTherapeutics Inc Total Capital Stock (Quarterly) (USD)|Brooklyn ImmunoTherapeutics Inc Return on Invested Capital|Brooklyn ImmunoTherapeutics Inc Quality Ratio Score|Brooklyn ImmunoTherapeutics Inc Momentum Score|Brooklyn ImmunoTherapeutics Inc Beta (1Y)|Brooklyn ImmunoTherapeutics Inc Sustainable Growth Rate (TTM)|Brooklyn ImmunoTherapeutics Inc Institutional Investor Ownership Percentage|Brooklyn ImmunoTherapeutics Inc Average Diluted Shares Outstanding (Quarterly)|Brooklyn ImmunoTherapeutics Inc Total Employees (Annual)|Brooklyn ImmunoTherapeutics Inc EPS Diluted (Quarterly) (USD)|Brooklyn ImmunoTherapeutics Inc Shares Outstanding|Brooklyn ImmunoTherapeutics Inc Repurchase of Capital Stock (Quarterly) (USD)|Brooklyn ImmunoTherapeutics Inc Ordinary Shares Number (Quarterly)|Brooklyn ImmunoTherapeutics Inc Payout Ratio|Brooklyn ImmunoTherapeutics Inc Quick Ratio (Quarterly)|Brooklyn ImmunoTherapeutics Inc Normalized Diluted EPS (Quarterly) (USD)|Brooklyn ImmunoTherapeutics Inc Stock Buybacks (Quarterly) (USD)|Brooklyn ImmunoTherapeutics Inc Effective Tax Rate (TTM)|Brooklyn ImmunoTherapeutics Inc Return on Equity|Brooklyn ImmunoTherapeutics Inc Net Income (TTM) (USD)|Brooklyn ImmunoTherapeutics Inc Revenue (TTM) (USD)|Brooklyn ImmunoTherapeutics Inc Dividend Per Share (Quarterly) (USD)|Brooklyn ImmunoTherapeutics Inc Revenue (Quarterly) (USD)|Brooklyn ImmunoTherapeutics Inc Gross Profit (Quarterly) (USD)|Brooklyn ImmunoTherapeutics Inc SG&A Expense (Quarterly) (USD)|Brooklyn ImmunoTherapeutics Inc Pre-Tax Income (Quarterly) (USD)|Brooklyn ImmunoTherapeutics Inc Net Income (Quarterly) (USD)|Brooklyn ImmunoTherapeutics Inc Net Interest Income (Quarterly) (USD)|Brooklyn ImmunoTherapeutics Inc Price (USD)|Brooklyn ImmunoTherapeutics Inc Total Return Price (USD)|Brooklyn ImmunoTherapeutics Inc Enterprise Value (USD)|Brooklyn ImmunoTherapeutics Inc 30-Day Average Daily Volume|Brooklyn ImmunoTherapeutics Inc 1 Year Price Returns (Daily)||
russ2000_1429|BTX|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric||
russ2000_1429|BTX|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|quarterly||
russ2000_1429|BTX|5|91.5|91.5||91.5|91.5|91.5|91.5|91.5||91.5|91.5||||1.44262295082||||1.44198895028|||1.44534412955||15.1818181818|91.5|91.5|91.5||||||30.3636363636|109.6||109.6|18.9166666667||91.5|||109.6|109.6|||91.5|||||109.6|109.6|109.6|121.666666667|1.44534412955|1.44534412955|1.44262295082|1.44495412844|||
russ2000_1429|BTX|6|2|2||2|2|2|2|2||2|2||||244||||181|||247||22|2|2|2||||||11|5||5|12||2|||5|5|||2|||||5|5|5|3|247|247|244|218|||
russ2000_1429|BTX|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily||
russ2000_1429|BTX|202003||||||||||||||||||||||||||||||||||41.5142||-0.0246||||||-0.0246|-0.3125||||||||1.0535|-1.0192|-1.0192||||||||
russ2000_1429|BTX|202006||||||||||||||||||||||||||||||||||41.5142||-0.049||||||-0.049|-3.5462||||||||1.0341|-2.0334|-2.0334||||||||
russ2000_1429|BTX|202009||||||||||||||||||||||||||||||||||41.5142||-0.0487||||||-0.0487|||||||||1.0841|-2.0201|-2.0201|-0.0126|||||||
russ2000_1429|BTX|202103|8.7136|8.4099||2.5922|8.9037|25.1194|3.902|21.2174||-4.4221|-55.0831||||-14.7905|||||||||0.1856|0.0534|1.812|0.2083||||||0.37|27.7994||-0.64|41.506||41.506|||-0.1168|-10.4751|||-22.7751|||||1.6366|-17.7023|-17.7023||3.72|3.72|146.7131|11946558.5333||49.8|14.4
russ2000_1429|BTX|202106|51.9412|50.1647||3.3498|8.9037|29.5268|7.6845|21.8423||35.1821|-65.1762||||-50.9027||||22.8861|||||1.9521|0.0233|3.6793|0.2243||||||15.7478|42.4482||-0.24|44.7074||44.7074|||-0.2388|-48.5498|||-31.8412|||||4.6204|-10.0853|-10.0853||18.01|18.01|755.7363|5887289.2333||11.49|12.07
russ2000_1429|BTX|202109|25.7583|24.3818||3.2128|8.9037|26.3541|4.5605|21.7935||13.0395|-151.2315||||-24.1221||||37.1185|||||1.6108|0.0233|0.9963|0.261||||||16.022|50.544||-1.7|52.0438||52.0438|||-0.1113|-3.5005|||-115.8631|||||4.2582|-86.0553|-86.0553|-0.0328|9.3|9.3|460.0363|874175.3||8.52|5.95
russ2000_1429|BTX|202112|||||||||||||||-10.1227||||16.6435|||||3.8763|||||||||35.6855||||||||||||||||||||||4.17|4.17|193.0516|604311.2667||2.72|2.26
russ2000_1429|BTX|202203|||||||||||||||-4.3101||||8.1421||||||||||||||||||||||||||||||||||||2.04|2.04|82.1983|345123.9|||